Correction

No authors listed

Published Erratum

No authors listed. Clin Pharmacol Drug Dev. 2020 Oct.

. 2020 Oct;9(7):889-890.

doi: 10.1002/cpdd.861. Epub 2020 Aug 9.

No abstract available

Figures

Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy Volunteers.
Erpenbeck VJ, Vets E, Gheyle L, Osuntokun W, Larbig M, Neelakantham S, Sandham D, Dubois G, Elbast W, Goldsmith P, Weiss M. Erpenbeck VJ, et al. Clin Pharmacol Drug Dev. 2016 Jul;5(4):306-13. doi: 10.1002/cpdd.244. Epub 2016 Mar 28. Clin Pharmacol Drug Dev. 2016. PMID: 27310331 Free PMC article. Clinical Trial.